In reality, increasing SLPI expression via an antimiR approach rather than inhibiting its expression using a miRNA mimic would be more likely to have therapeutic value for CF, where SLPI’s antiprotease and immune-modulator functions would be of value. Here, SLPI is linked to cystic fibrosis.